Analytical Methods for the Standardization of Quantitative BCR ABL1 Testing Results

被引：0

作者：

Labouner, E. ^{[1
]}

Wolf, W. Laosinchai ^{[1
]}

Hui, F. ^{[1
]}

Hedges, J. ^{[1
]}

Brown, J. ^{[1
]}

机构：

[1] Asuragen Inc, Austin, TX USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2010年 / 12卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：868 / 868

页数：1

共 50 条

[21] Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Innes, Andrew J.
Hayden, Chloe
Orovboni, Victoria
Claudiani, Simone
Fernando, Fiona
Khan, Afzal
Rees, David
Byrne, Jennifer
Gallipoli, Paolo
Francis, Sebastian
Copland, Mhairi
Horne, Gillian
Raghavan, Manoj
Arnold, Claire
Collins, Angela
Cranfield, Tanya
Cunningham, Nicholas
Danga, Akila
Forsyth, Peter
Frewin, Rebecca
Garland, Paula
Hannah, Guy
Avenoso, Daniele
Hassan, Sandra
Huntly, Brian J. P.
Husain, Jissan
Makkuni, Sudhakaran
Rothwell, Kate
Khorashad, Jamshid
Apperley, Jane F.
Milojkovic, Dragana
LEUKEMIA, 2024, : 2443 - 2455
[22] A Single NGS based Assay for Simultaneous Identification of BCR/ABL1 Fusion and ABL1 Sequencing Detects Resistance Mutation and Subclones
Ruiz-Cordero, R.
Farhana, N. R.
Chen, W.
Floyd, K.
Barkoh, B.
Routbort, M. J.
Cortes, J. E.
Haffield, D. Z.
Luthra, R.
Medeiros, J. L.
Patel, K. P.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 931 - 931
[23] Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
Benjamin Podvin
Hélène Guermouche
Pauline Roynard
Laure Goursaud
Céline Berthon
Mahdi Ouafi
Elise Fourner
Nicolas Duployez
Olivier Nibourel
Catherine Roche-Lestienne
Annals of Hematology, 2022, 101 : 2093 - 2095
[24] Distinct Pattern of ABL1 Genomic Breakpoints in Chronic Myeloid Leukemia and BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Analysis of 884 Patients with Minor and Major BCR::ABL1 Fusion
Hovorkova, Lenka
Winkowska, Lucie
Krotka, Justina
Krumbholz, Manuela
Meyer, Claus
Sutton, Rosemary
Henderson, Michelle
Clappier, Emmanuelle
Chiaretti, Sabina
Sramkova, Lucie
Stary, Jan
Benesova, Adela
Polakova, Katerina Machova
Marschalek, Rolf
Metzler, Markus
Cazzaniga, Giovanni
Cario, Gunnar
Trka, Jan
Zaliova, Marketa
Zuna, Jan
BLOOD, 2023, 142
[25] Ptprg and BCR/ABL1 Expression In CML Patients At Diagnosis and Upon TKI Treatment: Preliminary Results
Monne, Maria
Piras, Giovanna
Vezzalini, Marzia
Bras, Antonella
Murineddu, Marco
Yassin, Mohamed A.
Al-Dewik, Nader I.
Latte, Giancarlo
Sorio, Claudio
BLOOD, 2013, 122 (21)
[26] FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Anna Virgili
Diana Brazma
Alistair G Reid
Julie Howard-Reeves
Mikel Valgañón
Anastasios Chanalaris
Valeria AS De Melo
David Marin
Jane F Apperley
Colin Grace
Ellie P Nacheva
Molecular Cytogenetics, 1
[27] Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Fontana, Diletta
Malighetti, Federica
Villa, Matteo
Zambon, Alfonso
Gambacorti-Passerini, Carlo
Mologni, Luca
LEUKEMIA, 2024, 38 (08) : 1843 - 1847
[28] Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist?
Nacheva, Ellie P.
Grace, Colin D.
Brazma, Diana
Gancheva, Katya
Howard-Reeves, Julie
Rai, Lena
Gale, Rosemary E.
Linch, David C.
Hills, Robert K.
Russell, Nigel
Burnett, Alan K.
Kottaridis, Panagiotis D.
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (04) : 541 - 550
[29] Mutational Profile of B-Lymphoblastic Leukemia with BCR::ABL1
Lai, Xiaoxuan
Hu, Collin
Tang, Guilin
Fang, Hong
Wang, Wei
Patel, Keyur
You, M. James
Medeiros, L. Jeffrey
Hu, Shimin
LABORATORY INVESTIGATION, 2024, 104 (03) : S1438 - S1438
[30] Normal & ABL1 Is a Tumor Suppressor and Therapeutic Target In BCR-ABL1-positive Leukemias
Dasgupta, Yashodhara
Koptyra, Mateusz
Nieborowska-Skorska, Margaret
Gillespie, Elisabeth Bolton
Stoklosa, Tomasz
Hoser, Grazyna
Wasik, Mariusz
Muschen, Markus
Richardson, Christine
Skorski, Tomasz
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →